EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Development of a Follow-Up Measure to Ensure Complete Screening for Colorectal Cancer

Elizabeth L Ciemins, Jeff T Mohl, Carlos A Moreno, Francis Colangelo, Robert A Smith, Mary Barton

JAMA Network Open · 25.03.2024 · 7 (3) · e242693

DOI: 10.1001/jamanetworkopen.2024.2693 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift JAMA Network Open, online erschienen am 25.03.2024. Verfasst von Elizabeth L Ciemins und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research and Analytics, American Medical Group Association, Alexandria, Virginia. Hauptthemen laut MEDLINE: Early Detection of Cancer, Neoplasms. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance The current quality performance measure for colorectal cancer (CRC) screening is limited to initial screening. Despite low rates, there is no measure for appropriate follow-up with colonoscopy after receipt of an abnormal result of a stool-based screening test (SBT) for CRC. A quality performance measure is needed.

Objective

To develop and test a quality performance measure for follow-up colonoscopy within 6 months of an abnormal result of an SBT for CRC. Design, Setting, and Participants This retrospective quality improvement study examined data from January 1, 2016, to December 31, 2020, with 2018 plus 6 months of follow-up as the primary measurement period to verify performance rates, specify a potential measure, and test for validity, reliability, and feasibility. The Optum Labs Data Warehouse (OLDW), a deidentified database of health care claims and clinical data, was accessed. The OLDW contains longitudinal health information on enrollees and patients, representing a diverse mixture of ages and geographic regions across the US. For the database study, adults from 38 health care organizations (HCOs) aged 50 to 75 years who completed an initial CRC SBT with an abnormal result were observed to determine follow-up colonoscopy rates within 6 months. Rates were stratified by race, ethnicity, sex, insurance, and test modality. Three HCOs participated in the feasibility field testing. Data were analyzed from June 1, 2022, to May 31, 2023. Main Outcome and Measures The primary outcome consisted of follow-up colonoscopy rates following an abnormal SBT result for CRC. Reliability statistics were also calculated across HCOs, race, ethnicity, and measurement year.

Results

Among 20 581 adults (48.6% men and 51.4% women; 307 [1.5%] Asian, 492 [7.2%] Black, 644 [3.1%] Hispanic, and 17 705 [86.0%] White; mean [SD] age, 63.6 [7.1] years) in 38 health systems, 47.9% had a follow-up colonoscopy following an abnormal SBT result for CRC within 6 months. There was significant variation between HCOs. Notably, significantly fewer Black patients (37.1% [95% CI, 34.6%-39.5%]) and patients with Medicare (49.2% [95% CI, 47.7%-50.6%]) or Medicaid (39.2% [95% CI, 36.3%-42.1%]) insurance received a follow-up colonoscopy. A quality performance measure that tracks rates of follow-up within 6 months of an abnormal SBT result was observed to be feasible, valid, and reliable, with a median reliability statistic between HCOs of 94.5% (range, 74.3%-99.7%). Conclusions and Relevance The findings of this observational study of 20 581 adults suggest that a measure of follow-up colonoscopy within defined periods after an abnormal result of an SBT test for CRC is warranted based on low current performance rates and would be feasible to collect by health systems and produce valid, reliable results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Early Detection of CancerNeoplasmsUnited StatesAdultMaleHumansAgedFemaleMiddle AgedFollow-Up StudiesMedicareReproducibility of ResultsRetrospective Studies

Autor:innen und Institutionen

  • Research and Analytics, American Medical Group Association, Alexandria, Virginia.
  • Now with Albany Medical College.
  • Allegheny Health Network, Pittsburgh, Pennsylvania.
  • Center for Cancer Screening, American Cancer Society, Atlanta, Georgia.
  • National Committee for Quality Assurance, Washington, DC.

Zitieren

APA

Ciemins, E. L., Mohl, J. T., Moreno, C. A., Colangelo, F., Smith, R. A., & Barton, M. (2024). Development of a Follow-Up Measure to Ensure Complete Screening for Colorectal Cancer. JAMA Network Open, 7(3), e242693. https://doi.org/10.1001/jamanetworkopen.2024.2693

Vancouver

Ciemins EL, Mohl JT, Moreno CA, Colangelo F, Smith RA, Barton M. Development of a Follow-Up Measure to Ensure Complete Screening for Colorectal Cancer. JAMA Network Open. 2024;7(3):e242693. doi:10.1001/jamanetworkopen.2024.2693

BibTeX
@article{Ciemins2024,
  author = {Ciemins, Elizabeth L and Mohl, Jeff T and Moreno, Carlos A and Colangelo, Francis and Smith, Robert A and Barton, Mary},
  title = {Development of a Follow-Up Measure to Ensure Complete Screening for Colorectal Cancer},
  journal = {JAMA Network Open},
  year = {2024},
  volume = {7},
  number = {3},
  pages = {e242693},
  doi = {10.1001/jamanetworkopen.2024.2693}
}
Kostenlos starten →